Biomea Fusion (BMEA) Price & Analysis

Compare

832 Followers

BMEA Stock Chart & Stats

Day’s Range― - ―

52-Week Range$1.29 - $13.07

Previous CloseN/A

Volume309.16K

Average Volume (3M)1.13M

Market Cap

$91.64M

Enterprise Value$23.96M

Total Cash (Recent Filing)$56.22M

Total Debt (Recent Filing)$7.05M

Price to Earnings (P/E)―

Beta1.35

Next Earnings

Nov 04, 2025

EPS Estimate

-0.33

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.51

Shares Outstanding59,508,520

10 Day Avg. Volume909,454

30 Day Avg. Volume1,126,399

Financial Highlights & Ratios

PEG Ratio-0.09

Price to Book (P/B)2.72

Price to Sales (P/S)0.00

P/FCF Ratio-1.16

Enterprise Value/Market Cap0.26

Enterprise Value/Revenue19.64

Enterprise Value/Gross Profit29.23

Enterprise Value/Ebitda-0.21

Forecast

1Y Price Target

$7.80

Price Target Upside406.49% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

Bulls Say, Bears Say

Bulls Say

Drug EfficacyBiomea Fusion presented data updates indicating that icovamenib helps in insulin production and glucose reduction, which is beneficial for type 2 diabetes patients.

Therapeutic PotentialIcovamenib's combination with low-dose semaglutide exhibited superior metabolic benefits compared to low-dose semaglutide alone.

Bears Say

Financial PerformanceBiomea announced 2Q25 financial results, posting EPS of ($0.51) compared to our estimate of ($0.46), and in line with consensus.

Stock TargetTarget reduced to $4 on significant dilution.

Biomea Fusion News

Biomea Fusion price target lowered to $10 from $30 at Scotiabank

Scotiabank lowered the firm’s price target on Biomea Fusion (BMEA) to $10 from $30 and keeps an Outperform...

4d ago

BMEA

Biomea Fusion price target lowered to $9 from $10 at Oppenheimer

Oppenheimer analyst Matthew Biegler lowered the firm’s price target on Biomea Fusion (BMEA) to $9 from $10 and...

5d ago

BMEA

Biomea Fusion files $300M mixed securities shelf

16:42 EDT Biomea Fusion (BMEA) files $300M mixed securities shelf Published first on TheFly – the ultimate source...

5d ago

BMEA

Biomea Fusion reports Q2 EPS (51c), consensus (51c)

“In the second quarter, we presented clinical and preclinical results with icovamenib that support its unique role as...

5d ago

BMEA

Biomea Fusion appoints Julianne Averill to board of directors

Biomea Fusion (BMEA) announced the appointment of Julianne Averill to its Board of Directors, effective July 22, 2025....

17d ago

BMEA

Biomea Fusion price target lowered to $9 from $22 at Citi

Citi lowered the firm’s price target on Biomea Fusion (BMEA) to $9 from $22 and keeps a Buy...

25d ago

BMEA

Promising Developments in Biomea Fusion’s Metabolic Programs Justify Buy Rating

Biomea Fusion, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from...

4d ago

BMEA

Biomea Fusion Reports Q2 2025 Financial Results

Biomea Fusion Inc ( ($BMEA) ) has released its Q2 earnings. Here is a breakdown of the information...

5d ago

BMEA

Biomea Fusion Announces Leadership Changes in Board

The latest announcement is out from Biomea Fusion ( ($BMEA) ). On July 22, 2025, Bihua Chen resigned...

17d ago

BMEA

Biomea Fusion’s Phase 2 Trial: A New Hope for Type 1 Diabetes Treatment

Biomea Fusion Inc (($BMEA)) announced an update on their ongoing clinical study. Biomea Fusion Inc. is conducting a...

1M ago

BMEA

Biomea Fusion’s BMF-219 Study: A Potential Game-Changer for Type 2 Diabetes

Biomea Fusion Inc (($BMEA)) announced an update on their ongoing clinical study. Biomea Fusion Inc. is conducting a...

1M ago

BMEA

Biomea Fusion’s BMF-219 Study Update: Implications for Investors

Biomea Fusion Inc (($BMEA)) announced an update on their ongoing clinical study. Biomea Fusion Inc. recently updated its...

1M ago

BMEA

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Galectin Therapeutics (GALT) 128.69%...

2M ago

NFE

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: ChargePoint Holdings (CHPT) 38.00%...

2M ago

CGC

BMEA FAQ

What was Biomea Fusion Inc’s price range in the past 12 months?

Biomea Fusion Inc lowest stock price was $1.29 and its highest was $13.07 in the past 12 months.

What is Biomea Fusion Inc’s market cap?

Biomea Fusion Inc’s market cap is $91.64M.

When is Biomea Fusion Inc’s upcoming earnings report date?

Biomea Fusion Inc’s upcoming earnings report date is Nov 04, 2025 which is in 86 days.

How were Biomea Fusion Inc’s earnings last quarter?

Biomea Fusion Inc released its earnings results on Aug 05, 2025. The company reported -$0.51 earnings per share for the quarter, beating the consensus estimate of -$0.531 by $0.021.

Is Biomea Fusion Inc overvalued?

According to Wall Street analysts Biomea Fusion Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Biomea Fusion Inc pay dividends?

Biomea Fusion Inc does not currently pay dividends.

What is Biomea Fusion Inc’s EPS estimate?

Biomea Fusion Inc’s EPS estimate is -0.33.

How many shares outstanding does Biomea Fusion Inc have?

Biomea Fusion Inc has 59,508,520 shares outstanding.

What happened to Biomea Fusion Inc’s price movement after its last earnings report?

Biomea Fusion Inc reported an EPS of -$0.51 in its last earnings report, beating expectations of -$0.531. Following the earnings report the stock price went up 0.633%.

Which hedge fund is a major shareholder of Biomea Fusion Inc?

Currently, no hedge funds are holding shares in BMEA

Biomea Fusion Stock Smart Score

Underperform

Fundamentals

Return on Equity

-170.53%

Trailing 12-Months

Asset Growth

-46.27%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Biomea Fusion Inc

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Biomea Fusion (BMEA) Earnings & Revenues

Historic Earnings Reports

BMEA Stock 12 Month Forecast

Average Price Target

$7.80

▲(406.49% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","11":"$11","2.75":"$2.75","5.5":"$5.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.75,5.5,8.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,2.2184615384615385,2.8669230769230767,3.5153846153846153,4.163846153846154,4.812307692307693,5.46076923076923,6.109230769230769,6.757692307692308,7.406153846153846,8.054615384615385,8.703076923076923,9.35153846153846,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,2.0492307692307694,2.5284615384615385,3.0076923076923077,3.486923076923077,3.966153846153846,4.445384615384615,4.924615384615384,5.403846153846153,5.883076923076923,6.362307692307692,6.841538461538462,7.320769230769231,{"y":7.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,1.756923076923077,1.9438461538461538,2.1307692307692307,2.3176923076923077,2.5046153846153847,2.691538461538461,2.878461538461538,3.065384615384615,3.252307692307692,3.439230769230769,3.626153846153846,3.813076923076923,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.42,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.33,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.5,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.04,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.88,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.89,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.99,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.57,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >